Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Acne Vulgaris - Research from University of Alabama provide new insights into acne vulgaris
Biopharmaceuticals - Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Bristol-Myers Squibb Company and AstraZeneca - Study Finds That ONGLYZA saxagliptin When Added to Metformin was Non-Inferior to JANUVIA sitagliptin When Added to Metformin in Reducing Hemoglobin HbA1c in Adults With Type 2 Diabetes Mellitus
Chagas Disease - Studies from University of California reveal new findings on Chagas disease
Clinical Trial Research - ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
Cystic Fibrosis - Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
Drug Resistance - Research results from Wayne State University update knowledge of drug resistance
Heart Failure - New heart failure research from M.Z. Hoque and co-researchers described
Life Sciences - Researchers from Spelman College report on findings in life sciences
Oncology - Northwestern University details research in oncology
Pharmaceuticals - Reports from Y.C. Yeh and colleagues advance knowledge in pharmaceuticals
Psoriasis - Study findings from E.A. Alwawi et al broaden understanding of psoriasis
Type 2 Diabetes - Study Finds That ONGLYZA(TM) (saxagliptin) When Added to Metformin was Non-Inferior to JANUVIA (sitagliptin) When Added to Metformin in Reducing Hemoglobin (HbA1c RIGHTPARE
Clinical Trial Research - Findings from Center for Drug Evaluation and Research advance knowledge in clinical trial research
Life Sciences - Reports from Sanofi Aventis advance knowledge in life sciences
Life Sciences - Researchers from Medical Research Council Toxicology Unit report recent findings in life sciences
Obesity and Diabetes - Data from Vanderbilt University advance knowledge in obesity and diabetes
Orthopedic Implants - Studies from Wright State University add new findings in the area of orthopedic implants
Allos Therapeutics, Inc. - Allos Therapeutics Announces U.S. Availability of FOLOTYN(TM) pralatrexate injection for Relapsed or Refractory Peripheral T-Cell Lymphoma
Depomed, Inc. - Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia
Diagnostics - BD Announces FDA 510(k) Clearance of BD Vacutainer(R) Rapid Serum Blood Collection Tube
Drug Development - Cipher announces enrollment of first patient in CIP-ISOTRETINOIN Phase III safety study
Drug Development - Sequella Receives American Recovery and Reinvestment Funding Through the NIH
Drug Safety - New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry
Enzon Pharmaceuticals, Inc. - PEGINTRON(R) Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma
Familial Hypercholesterolemia - Welchol(R) (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
Fenton Communications - Fenton Communications Names Social Marketing Expert Rob Anderson as Managing Director of New York Office
Food Poisoning - USDA Joins FDA Efforts on New Food Safety Regulations
GE Healthcare - GE Healthcare Introduces CARESCAPE Monitor B850
General Electric - GE Developing Health Globally Commissions First Hospitals in Cambodia
Genzyme Corporation - Genzyme Receives FDA Complete Response Letter for Clolar
Hard to Treat Diseases - Hard to Treat Diseases HTDS Obtains GMP Certificate from Russian FDA
Harvard Clinical Research Institute - Harvard Clinical Research Institute Enrolls First Patients into DAPT Study to Advance Understanding of Dual Antiplatelet Therapy Following Drug-Eluting Stent Procedures
Hepatitis C Virus - Pharmasset Nominates PSI-879 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development
Homeland Security - PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
ICCR, Nyc - Investors Vindicated by Court Ruling on Genetically Modified Sugar Beets, New Concerns Raised About Inadequate EPA Review of Monsanto Corn Product
JohnsonDiversey Inc. - JohnsonDiversey and Clayton, Dubilier & Rice Announce Equity Investment and Company Recapitalization
Labopharm Inc. - Labopharm announces that its trazodone API supplier has resolved outstanding manufacturing issues with the FDA
Lantheus Medical Imaging, Inc. - Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S., Presented At MRA-Club 09: the 21st Annual International Conference on Magnetic Resonance Angiography
Lupus - National Report Shines Light on Lupus 50-Year Treatment Drought
Mental Health - SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders
Pharmaceuticals - Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
Pharmaceuticals - Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
Pharmaceuticals - Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Pico-Tesla Magnetic Therapies, Inc. - Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic Magneceutical(TM) Therapy for Parkinson's Disease
Prostate Cancer - FDA Grants Additional Fast Track Designation for OGX-011 in Combination with First Line Chemotherapy
Prostate Cancer - OncoGenex Pharmaceuticals CEO Named Canada's Pacific Ernst & Young's Entrepreneur of the Year(R) in the Health Sciences Category
U.S. Food and Drug Administration - FDA Transparency Task Force to Hold 2nd Public Meeting on Ensuring That Agency Information is Useful, Understandable, Accessible
U.S. Potato Board - United States Potato Growers Respond to Center for Science in the Public Interest's Risky Foods List, Provides Important Facts About Food Safety
Vermillion, Inc. - Vermillion Announces Return of Eric Fung, M.D., Ph.D.